Skip to content

Insider · CIK 0001988262

Frankenius Equity AB

owner

Files at TLSI (TriSalus Life Sciences, Inc.). First filing Dec 19, 2024, latest Dec 19, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$250k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TLSI: TriSalus Life Sciences, Inc.

TLSIOct 9, 2026 · close 4.06

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
TLSIbuy
TriSalus Life Sciences, Inc.
$250k
62,972 shares
+1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 10, 2025TLSI
TriSalus Life Sciences, Inc.
JOther
Series A Convertible Preferred Stockderivative
+205,853$0.00$0435,853Feb 11, 2025
Dec 17, 2024TLSI
TriSalus Life Sciences, Inc.
POpen-market purchase
Common Stock
+62,972$3.97$250k6,230,748Dec 19, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Frankenius Equity AB: insider trades and track record | InsiderTell